In the latest trading session, 0.6 million Mind Medicine Inc (NASDAQ:MNMD) shares changed hands as the company’s beta touched 1.71. With the company’s most recent per share price at $7.03 changing hands around $0.64 or 9.85% at last look, the market valuation stands at $515.16M. MNMD’s current price is a discount, trading about -73.83% off its 52-week high of $12.22. The share price had its 52-week low at $3.49, which suggests the last value was 50.36% up since then. When we look at Mind Medicine Inc’s average trading volume, we note the 10-day average is 1.43 million shares, with the 3-month average coming to 1.36 million.
Analysts gave the Mind Medicine Inc (MNMD) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.11. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended MNMD as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Mind Medicine Inc’s EPS for the current quarter is expected to be -0.27.
Mind Medicine Inc (NASDAQ:MNMD) trade information
Instantly MNMD is in green as seen in intraday trades today. With action -13.38%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 0.93%, with the 5-day performance at -13.38% in the red. However, in the 30-day time frame, Mind Medicine Inc (NASDAQ:MNMD) is 0.07% up. Looking at the short shares, we see there were 9.98 million shares sold at short interest cover period of 8.83 days.
The consensus price target for the stock as assigned by Wall Street analysts is 14, meaning bulls need an upside of 49.79% from its recent market value. According to analyst projections, MNMD’s forecast low is 14 with 14 as the target high. To hit the forecast high, the stock’s price needs a -99.15% plunge from its current level, while the stock would need to soar -99.15% for it to hit the projected low.
Mind Medicine Inc (MNMD) estimates and forecasts
Data shows that the Mind Medicine Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -17.26% over the past 6 months, a 35.66% in annual growth rate that is considerably higher than the industry average of 16.70%.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 2.29%. The 2025 estimates are for Mind Medicine Inc earnings to increase by 40.57%.
MNMD Dividends
Mind Medicine Inc is expected to release its next quarterly earnings report in February.
Mind Medicine Inc (NASDAQ:MNMD)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.70% of Mind Medicine Inc shares while 68.23% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 68.71%.
Among Mutual Funds, the top two as of Oct 31, 2024 were iShares Russell 2000 ETF and Vanguard Extended Market Index Fund. With 1.87 shares estimated at $12.79 million under it, the former controlled 2.55% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 1.43% of the shares, roughly 1.05 shares worth around $7.18 million.
